These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 16140224)

  • 1. Effect of cetirizine dihydrochloride on the airway response to hypertonic saline aerosol in patients with chronic obstructive pulmonary disease (COPD).
    Grönke L; Schlenker J; Holz O; Out TA; Magnussen H; Jörres RA
    Respir Med; 2005 Oct; 99(10):1241-8. PubMed ID: 16140224
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fast onset of effect of budesonide/formoterol versus salmeterol/fluticasone and salbutamol in patients with chronic obstructive pulmonary disease and reversible airway obstruction.
    Lindberg A; Szalai Z; Pullerits T; Radeczky E
    Respirology; 2007 Sep; 12(5):732-9. PubMed ID: 17875063
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Airway response to inhaled hypertonic saline in patients with moderate to severe chronic obstructive pulmonary disease.
    Taube C; Holz O; Mücke M; Jörres RA; Magnussen H
    Am J Respir Crit Care Med; 2001 Nov; 164(10 Pt 1):1810-5. PubMed ID: 11734428
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tiotropium administered by a pressurized metered dose inhaler (pMDI) and spacer produces a similar bronchodilator response as that administered by a Rotahaler in adult subjects with stable moderate-to-severe COPD.
    Brashier B; Dhembare P; Jantikar A; Mahadik P; Gokhale P; Gogtay JA; Salvi SS
    Respir Med; 2007 Dec; 101(12):2464-71. PubMed ID: 17719763
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of acute bronchodilator reversibility in patients with symptoms of GOLD stage I COPD.
    O'Donnell DE; Laveneziana P; Ora J; Webb KA; Lam YM; Ofir D
    Thorax; 2009 Mar; 64(3):216-23. PubMed ID: 19052054
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effectiveness and safety of hypertonic saline inhalation combined with exercise training in patients with chronic obstructive pulmonary disease: a randomized trial.
    Valderramas SR; Atallah AN
    Respir Care; 2009 Mar; 54(3):327-33. PubMed ID: 19245725
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bronchodilatory effects of NVA237, a once daily long-acting muscarinic antagonist, in COPD patients.
    Fogarty C; Hattersley H; Di Scala L; Drollmann A
    Respir Med; 2011 Mar; 105(3):337-42. PubMed ID: 21144724
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sputum eosinophilia and the short term response to inhaled mometasone in chronic obstructive pulmonary disease.
    Brightling CE; McKenna S; Hargadon B; Birring S; Green R; Siva R; Berry M; Parker D; Monteiro W; Pavord ID; Bradding P
    Thorax; 2005 Mar; 60(3):193-8. PubMed ID: 15741434
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-term effects of budesonide on inflammatory status in COPD.
    Boorsma M; Lutter R; van de Pol MA; Out TA; Jansen HM; Jonkers RE
    COPD; 2008 Apr; 5(2):97-104. PubMed ID: 18415808
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intravenous aminophylline in patients admitted to hospital with non-acidotic exacerbations of chronic obstructive pulmonary disease: a prospective randomised controlled trial.
    Duffy N; Walker P; Diamantea F; Calverley PM; Davies L
    Thorax; 2005 Sep; 60(9):713-7. PubMed ID: 15939732
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Modulation of operational lung volumes with the use of salbutamol in COPD patients accomplishing upper limbs exercise tests.
    Porto EF; Castro AA; Nascimento O; Oliveira RC; Cardoso F; Jardim JR
    Respir Med; 2009 Feb; 103(2):251-7. PubMed ID: 18930646
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhaled corticosteroids as additional treatment in alpha-1-antitrypsin-deficiency-related COPD.
    Corda L; Bertella E; La Piana GE; Boni E; Redolfi S; Tantucci C
    Respiration; 2008; 76(1):61-8. PubMed ID: 18319586
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Can hypertonic saline inhalation influence preformed chemokine and mediator release in induced sputum of chronic obstructive pulmonary disease patients? Comparison with isotonic saline.
    Cianchetti S; Bacci E; Bartoli ML; Ruocco L; Pavia T; Dente FL; Di Franco A; Vagaggini B; Paggiaro P
    Clin Exp Allergy; 2007 Dec; 37(12):1819-26. PubMed ID: 17941910
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Montelukast attenuates the airway response to hypertonic saline in moderate-to-severe COPD.
    Zühlke IE; Kanniess F; Richter K; Nielsen-Gode D; Böhme S; Jörres RA; Magnussen H
    Eur Respir J; 2003 Dec; 22(6):926-30. PubMed ID: 14680080
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Superiority of "triple" therapy with salmeterol/fluticasone propionate and tiotropium bromide versus individual components in moderate to severe COPD.
    Singh D; Brooks J; Hagan G; Cahn A; O'Connor BJ
    Thorax; 2008 Jul; 63(7):592-8. PubMed ID: 18245142
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Changes in sputum composition during 15 min of sputum induction in healthy subjects and patients with asthma and chronic obstructive pulmonary disease.
    Toungoussova O; Migliori GB; Foschino Barbaro MP; Esposito LM; Dragonieri S; Carpagnano GE; Salerno FG; Neri M; Spanevello A
    Respir Med; 2007 Jul; 101(7):1543-8. PubMed ID: 17258444
    [TBL] [Abstract][Full Text] [Related]  

  • 17. New developments in the treatment of COPD: comparing the effects of inhaled corticosteroids and N-acetylcysteine.
    van Overveld FJ; Demkow U; Górecka D; de Backer WA; Zielinski J
    J Physiol Pharmacol; 2005 Sep; 56 Suppl 4():135-42. PubMed ID: 16204787
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The efficacy of tiotropium administered via Respimat Soft Mist Inhaler or HandiHaler in COPD patients.
    van Noord JA; Cornelissen PJ; Aumann JL; Platz J; Mueller A; Fogarty C
    Respir Med; 2009 Jan; 103(1):22-9. PubMed ID: 19022642
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bronchodilator reversibility, airway eosinophilia and anti-inflammatory effects of inhaled fluticasone in COPD are not related.
    Reid DW; Wen Y; Johns DP; Williams TJ; Ward C; Walters EH
    Respirology; 2008 Nov; 13(6):799-809. PubMed ID: 18811878
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Efficacy of tiotropium bromide (Spiriva) in patients with chronic-obstructive pulmonary disease (COPD) of different severities].
    Beeh KM; Beier J; Buhl R; Stark-Lorenzen P; Gerken F; Metzdorf N;
    Pneumologie; 2006 Jun; 60(6):341-6. PubMed ID: 16761228
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.